Status:
COMPLETED
A Feasibility Study to Collect Data in Patients With Haemophilia
Lead Sponsor:
AstraZeneca
Conditions:
Hemophilia
Eligibility:
MALE
18+ years
Brief Summary
The purpose of this study is to collect reference data in patients with haemophilia. The study will also collect and store blood samples for potential future exploratory research in the disease area.
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Patients with haemophilia, all severities
- At least 18 years old.
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00798499
Start Date
December 1 2008
End Date
June 1 2009
Last Update
July 2 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Malmo, Sweden
2
Research Site
Stockholm, Sweden